11:27 AM EST - Oncolytics Biotech Inc : Announced the formation of its Gastrointestinal Tumor Scientific Advisory Board (SAB), a group of leading oncology experts assembled to guide the Company’s clinical and regulatory strategy for developing pelareorep as a treatment for GI cancers. Oncolytics Biotech Inc
shares N.ONCY are trading off $0.10 at $0.99.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=6764893778256300
